Pfizer looks at building major gene therapy manufacturing facility in North Carolina

10 Mar

fiercepharma.com 08 Mar, 2017

Pfizer is now looking at building a gene therapy production facility in North Carolina, United States where the biotech is based. New gene therapy site in Sanford work is still in the preliminary stages. The drug maker currently is erecting a $200 million biologics and vaccines production facility at its campus in Andover.

Leave a Reply

Your email address will not be published. Required fields are marked *